MORRISVILLE, N.C.--(BUSINESS WIRE)--etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management, announced today that it’s Board of Directors has retained Emerging Growth Equities, Ltd. (EGE) as its exclusive financial advisor to assist in evaluating strategic or other alternatives with a focus on acquisitions that may be available to the Company.
